{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:47:47Z","timestamp":1785851267417,"version":"3.56.0"},"reference-count":38,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["9-22-PDFPM-04"],"award-info":[{"award-number":["9-22-PDFPM-04"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["NIDDK UM1 DK078616"],"award-info":[{"award-number":["NIDDK UM1 DK078616"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["75N92021D00001"],"award-info":[{"award-number":["75N92021D00001"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["75N92021D00002"],"award-info":[{"award-number":["75N92021D00002"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["75N92021D00003"],"award-info":[{"award-number":["75N92021D00003"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["75N92021D00004"],"award-info":[{"award-number":["75N92021D00004"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["75N92021D00005"],"award-info":[{"award-number":["75N92021D00005"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>The metabolic mechanisms underlying insulin resistance are not fully understood. Metabolomic profiling can reveal compartment-specific variations and identify individuals at risk for type 2 diabetes (T2D).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To characterize insulin-induced metabolomic changes during a hyperinsulinemic\u2013euglycemic clamp and evaluate a derived risk score's predictive value for T2D.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>Clamp studies were conducted in 80 adults (38 with T2D, 42 without) to measure plasma and muscle metabolites in fasting and hyperinsulinemic states. An insulin resistance metabolomic score was developed and tested in a prospective case\u2013control study (367 cases, 910 controls) from the Women's Health Initiative (28.5-year follow-up).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measures<\/jats:title>\n                    <jats:p>Metabolite changes during hyperinsulinemia and incident T2D.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Hyperinsulinemia altered 79.5% of plasma metabolites (notably fatty acids, lactate, and pyruvate) and 15.8% of muscle metabolites (eg, branched-chain and aromatic amino acids). T2D was associated with higher triglycerides and lower tricarboxylic acid intermediates during clamp. Adiposity amplified insulin-induced increases in plasma lipids. The risk score predicted incident T2D (hazard ratio, 1.20 per SD; 95% CI, 1.09-1.32; P = 7.4 \u00d7 10\u22124).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Compartment-specific metabolic responses to insulin are shaped by adiposity and predict future T2D risk, supporting use of metabolomic signatures for early identification and prevention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf454","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T11:26:09Z","timestamp":1754911569000},"page":"820-831","source":"Crossref","is-referenced-by-count":3,"title":["Compartment-specific Metabolic Alterations to Insulin Reflect Adiposity-driven Variation and Predict Type 2 Diabetes"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6135-9998","authenticated-orcid":false,"given":"Magdalena","family":"Sevilla-Gonz\u00e1lez","sequence":"first","affiliation":[{"name":"Clinical and Translational Epidemiology Unit, Mongan Institute, Massachusetts General Hospital , Boston, MA 02114 ,","place":["USA"]},{"name":"Department of Medicine, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]},{"name":"Programs in Metabolism and Medical & Population Genetics, The Broad Institute of MIT and Harvard , Cambridge, MA 02142 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A","family":"Hanson","sequence":"additional","affiliation":[{"name":"Clinical and Translational Epidemiology Unit, Mongan Institute, Massachusetts General Hospital , Boston, MA 02114 ,","place":["USA"]},{"name":"Programs in Metabolism and Medical & Population Genetics, The Broad Institute of MIT and Harvard , Cambridge, MA 02142 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Islam","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, McGill University , Montreal, QC , H3A 0C7","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hsu","sequence":"additional","affiliation":[{"name":"Clinical and Translational Epidemiology Unit, Mongan Institute, Massachusetts General Hospital , Boston, MA 02114 ,","place":["USA"]},{"name":"Programs in Metabolism and Medical & Population Genetics, The Broad Institute of MIT and Harvard , Cambridge, MA 02142 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Tsoukas","sequence":"additional","affiliation":[{"name":"Metabolic Disorders and Complications Program, Research Institute of McGill University Health Centre , Montreal, QC , H4A 3J","place":["Canada"]},{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine and Health Sciences, McGill University , Montreal, QC , H3A 1A1","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Errol B","family":"Marliss","sequence":"additional","affiliation":[{"name":"Metabolic Disorders and Complications Program, Research Institute of McGill University Health Centre , Montreal, QC , H4A 3J","place":["Canada"]},{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine and Health Sciences, McGill University , Montreal, QC , H3A 1A1","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander P","family":"Reiner","sequence":"additional","affiliation":[{"name":"Division of Public Health Sciences, Fred Hutchinson Cancer Center , Seattle, WA 98109 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Gravel","sequence":"additional","affiliation":[{"name":"McGill Genome Centre, McGill University , Montreal, QC , H3A 2T8","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Kooperberg","sequence":"additional","affiliation":[{"name":"Division of Public Health Sciences, Fred Hutchinson Cancer Center , Seattle, WA 98109 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8259-9245","authenticated-orcid":false,"given":"Clary B","family":"Clish","sequence":"additional","affiliation":[{"name":"Metabolomics Platform, The Broad Institute of MIT and Harvard , Cambridge, MA 02142 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa K","family":"Manning","sequence":"additional","affiliation":[{"name":"Clinical and Translational Epidemiology Unit, Mongan Institute, Massachusetts General Hospital , Boston, MA 02114 ,","place":["USA"]},{"name":"Department of Medicine, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]},{"name":"Programs in Metabolism and Medical & Population Genetics, The Broad Institute of MIT and Harvard , Cambridge, MA 02142 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2730-1204","authenticated-orcid":false,"given":"Rob","family":"Sladek","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, McGill University , Montreal, QC , H3A 0C7","place":["Canada"]},{"name":"Metabolic Disorders and Complications Program, Research Institute of McGill University Health Centre , Montreal, QC , H4A 3J","place":["Canada"]},{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine and Health Sciences, McGill University , Montreal, QC , H3A 1A1","place":["Canada"]},{"name":"McGill Genome Centre, McGill University , Montreal, QC , H3A 2T8","place":["Canada"]},{"name":"Division of Clinical and Translational Research, Department of Medicine, Faculty of Medicine and Health Sciences, McGill University , Montreal, QC , H3G 2M1","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B","family":"Meigs","sequence":"additional","affiliation":[{"name":"Department of Medicine, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]},{"name":"Programs in Metabolism and Medical & Population Genetics, The Broad Institute of MIT and Harvard , Cambridge, MA 02142 ,","place":["USA"]},{"name":"Division of General Internal Medicine, Massachusetts General Hospital , Boston, MA 02114 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0569-4307","authenticated-orcid":false,"given":"Sergio A","family":"Burgos","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine and Health Sciences, McGill University , Montreal, QC , H3A 1A1","place":["Canada"]},{"name":"Metabolomics Platform, The Broad Institute of MIT and Harvard , Cambridge, MA 02142 ,","place":["USA"]},{"name":"Department of Animal Science, Faculty of Agricultural and Environmental Science, McGill University , Sainte-Anne-de-Bellevue, QC , H9X 3V9","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"issue":"10","key":"2026021918523589900_dgaf454-B1","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1007\/s00125-020-05211-7","article-title":"The clinical consequences of heterogeneity within and between different diabetes types","volume":"63","author":"Redondo","year":"2020","journal-title":"Diabetologia"},{"issue":"4","key":"2026021918523589900_dgaf454-B2","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol Rev"},{"issue":"8825","key":"2026021918523589900_dgaf454-B3","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0140-6736(92)92814-V","article-title":"Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study","volume":"340","author":"Martin","year":"1992","journal-title":"Lancet"},{"issue":"suppl_2","key":"2026021918523589900_dgaf454-B4","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.2337\/dc09-S302","article-title":"Skeletal muscle insulin resistance is the primary defect in type 2 diabetes","volume":"32","author":"DeFronzo","year":"2009","journal-title":"Diabetes Care"},{"issue":"1","key":"2026021918523589900_dgaf454-B5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1172\/JCI77812","article-title":"The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux","volume":"126","author":"Samuel","year":"2016","journal-title":"J Clin Invest"},{"issue":"3","key":"2026021918523589900_dgaf454-B6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11306-020-01653-7","article-title":"Metabolomics analyses in non-diabetic middle-aged individuals reveal metabolites impacting early glucose disturbances and insulin sensitivity","volume":"16","author":"Bos","year":"2020","journal-title":"Metabolomics"},{"issue":"2","key":"2026021918523589900_dgaf454-B7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/gutjnl-2018-316155","article-title":"Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial","volume":"68","author":"Heianza","year":"2019","journal-title":"Gut"},{"issue":"3","key":"2026021918523589900_dgaf454-B8","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/ajcn\/nqy262","article-title":"Plasma metabolites predict both insulin resistance and incident type 2 diabetes: a metabolomics approach within the Prevenci\u00f3n con Dieta Mediterr\u00e1nea (PREDIMED) study","volume":"109","author":"Papandreou","year":"2019","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"2026021918523589900_dgaf454-B9","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.2337\/db13-0570","article-title":"Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach","volume":"62","author":"Menni","year":"2013","journal-title":"Diabetes"},{"issue":"3","key":"2026021918523589900_dgaf454-B10","first-page":"E214","article-title":"Glucose clamp technique: a method for quantifying insulin secretion and resistance","volume":"237","author":"DeFronzo","year":"1979","journal-title":"Am J Physiol"},{"issue":"10","key":"2026021918523589900_dgaf454-B11","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41580-018-0044-8","article-title":"Metabolites as regulators of insulin sensitivity and metabolism","volume":"19","author":"Yang","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"2026021918523589900_dgaf454-B12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"9","key":"2026021918523589900_dgaf454-B13","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"issue":"8","key":"2026021918523589900_dgaf454-B14","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/CIRCULATIONAHA.117.029468","article-title":"Metabolic predictors of incident coronary heart disease in women","volume":"137","author":"Paynter","year":"2018","journal-title":"Circulation"},{"key":"2026021918523589900_dgaf454-B15","unstructured":"Sevilla M. \u00a0Supplemental data for Compartment-Specific Metabolic Alterations to Insulin Reflect Adiposity-Driven Variation and Predict Type 2 Diabetes. Figshare. 2025. 10.6084\/m9.figshare.29803454"},{"issue":"6","key":"2026021918523589900_dgaf454-B16","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1096\/fj.11-198093","article-title":"The dynamic range of the human metabolome revealed by challenges","volume":"26","author":"Krug","year":"2012","journal-title":"FASEB J"},{"issue":"4","key":"2026021918523589900_dgaf454-B17","first-page":"831","article-title":"Adaptations of skeletal muscle to endurance exercise and their metabolic consequences","volume":"56","author":"Holloszy","year":"1984","journal-title":"J Appl Physiol Respir Environ Exerc Physiol"},{"issue":"7503","key":"2026021918523589900_dgaf454-B18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature13478","article-title":"The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes","volume":"510","author":"Perry","year":"2014","journal-title":"Nature"},{"issue":"3","key":"2026021918523589900_dgaf454-B19","doi-asserted-by":"crossref","first-page":"R199","DOI":"10.1530\/JME-13-0277","article-title":"Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease","volume":"52","author":"Nielsen","year":"2014","journal-title":"J Mol Endocrinol"},{"issue":"1","key":"2026021918523589900_dgaf454-B20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1373\/clinchem.2011.169573","article-title":"Metabolomics and cardiovascular biomarker discovery","volume":"58","author":"Rhee","year":"2012","journal-title":"Clin Chem"},{"issue":"5 Pt 1","key":"2026021918523589900_dgaf454-B21","first-page":"E736","article-title":"Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans","volume":"259","author":"Bonadonna","year":"1990","journal-title":"Am J Physiol"},{"issue":"6","key":"2026021918523589900_dgaf454-B22","first-page":"E1063","article-title":"Regulation of free fatty acid metabolism by insulin in humans: role of lipolysis and reesterification","volume":"263","author":"Campbell","year":"2006","journal-title":"Am J Physiol"},{"issue":"1","key":"2026021918523589900_dgaf454-B23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/jcem-72-1-96","article-title":"The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus","volume":"72","author":"Groop","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026021918523589900_dgaf454-B24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/jcem-64-1-17","article-title":"Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus","volume":"64","author":"Chen","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026021918523589900_dgaf454-B25","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3945\/ajcn.114.092544","article-title":"Serum pentadecanoic acid (15:0), a short-term marker of dairy food intake, is inversely associated with incident type 2 diabetes and its underlying disorders","volume":"100","author":"Santaren","year":"2014","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"2026021918523589900_dgaf454-B26","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S2213-8587(14)70146-9","article-title":"Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case\u2013cohort study","volume":"2","author":"Forouhi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"2026021918523589900_dgaf454-B27","doi-asserted-by":"crossref","first-page":"e0145850","DOI":"10.1371\/journal.pone.0145850","article-title":"Catabolism of branched chain amino acids contributes significantly to synthesis of odd-chain and even-chain fatty acids in 3T3-L1 adipocytes","volume":"10","author":"Crown","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"2026021918523589900_dgaf454-B28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nchembio.1961","article-title":"Branched-chain amino acid catabolism fuels adipocyte differentiation and lipogenesis","volume":"12","author":"Green","year":"2016","journal-title":"Nat Chem Biol"},{"issue":"2 Pt. 1","key":"2026021918523589900_dgaf454-B29","first-page":"E273","article-title":"Insulin and hyperaminoacidemia regulate by a different mechanism leucine turnover and oxidation in obesity","volume":"270","author":"Luzi","year":"1996","journal-title":"Am J Physiol"},{"issue":"3","key":"2026021918523589900_dgaf454-B30","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2337\/diabetes.51.3.599","article-title":"Mechanism of amino acid-induced skeletal muscle insulin resistance in humans","volume":"51","author":"Krebs","year":"2002","journal-title":"Diabetes"},{"issue":"15","key":"2026021918523589900_dgaf454-B31","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJM196910092811503","article-title":"Plasma amino acid levels and insulin secretion in obesity","volume":"281","author":"Felig","year":"1969","journal-title":"N Engl J Med"},{"issue":"4","key":"2026021918523589900_dgaf454-B32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","article-title":"A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance","volume":"9","author":"Newgard","year":"2009","journal-title":"Cell Metab"},{"issue":"9","key":"2026021918523589900_dgaf454-B33","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2337\/dc08-2075","article-title":"Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women","volume":"32","author":"Huffman","year":"2009","journal-title":"Diabetes Care"},{"issue":"15","key":"2026021918523589900_dgaf454-B34","doi-asserted-by":"crossref","first-page":"11348","DOI":"10.1074\/jbc.M109.075184","article-title":"Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels","volume":"285","author":"Herman","year":"2010","journal-title":"J Biol Chem"},{"issue":"3","key":"2026021918523589900_dgaf454-B35","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1210\/me.2014-1275","article-title":"Inflammation and ER stress regulate branched-chain amino acid uptake and metabolism in adipocytes","volume":"29","author":"Burrill","year":"2015","journal-title":"Mol Endocrinol"},{"issue":"4","key":"2026021918523589900_dgaf454-B36","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jcjd.2017.09.002","article-title":"Plasma palmitoyl-carnitine (AC16:0) is a marker of increased postprandial nonesterified incomplete fatty acid oxidation rate in adults with type 2 diabetes","volume":"42","author":"Bouchouirab","year":"2018","journal-title":"Can J Diabetes"},{"issue":"1","key":"2026021918523589900_dgaf454-B37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cmet.2007.10.013","article-title":"Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance","volume":"7","author":"Koves","year":"2008","journal-title":"Cell Metab"},{"issue":"4","key":"2026021918523589900_dgaf454-B38","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2337\/db06-1656","article-title":"Visceral fat adipokine secretion is associated with systemic inflammation in obese humans","volume":"56","author":"Fontana","year":"2007","journal-title":"Diabetes"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf454\/64017373\/dgaf454.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/3\/820\/64017373\/dgaf454.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/3\/820\/64017373\/dgaf454.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T23:52:54Z","timestamp":1771545174000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/3\/820\/8231665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,8,11]]},"published-print":{"date-parts":[[2026,2,20]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf454","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,8,11]]}}}